C. Rémuzat
Impact in
- Economics and Econometrics top 5%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
-
- Biosimilars and Bioanalytical Methods
Papers in
-
- Pharmaceutical Economics and Policy 46
- Health Systems, Economic Evaluations, Quality of Life 42
- Economic and Financial Impacts of Cancer 5
- Healthcare Policy and Management 4
-
- Pharmaceutical studies and practices 9
- Co-authors
- Mondher Toumi (57 shared papers)Pascal Auquier (7 shared papers)Ehab Y. Hanna (2 shared papers)A. Millier (6 shared papers)Samuel Aballéa (10 shared papers)Matthias C. Angermeyer (2 shared papers)Bruno Falissard (5 shared papers)J Dorey (1 shared paper)
- Journals
- Value in Health (36 papers)International Journal of Social Psychiatry (1 paper)BMC Psychiatry (1 paper)Targeted Oncology (1 paper)Heart Failure Reviews (1 paper)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
C. Rémuzat
60 papers receiving 724 citations
Peers
Comparison fields: 5 of 103
- Economics and Econometrics 346
- Immunology 166
- Pediatrics, Perinatology and Child Health 96
- Biological Psychiatry 11
- Pharmacology 35
Countries citing papers authored by C. Rémuzat
This map shows the geographic impact of C. Rémuzat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Rémuzat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Rémuzat more than expected).
Fields of papers citing papers by C. Rémuzat
This network shows the impact of papers produced by C. Rémuzat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Rémuzat. The network helps show where C. Rémuzat may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Rémuzat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 113 | |
| 2 | 2017 | 86 | |
| 3 | 2015 | 68 | |
| 4 | 2017 | 64 | |
| 5 | 2013 | 51 | |
| 6 | 2017 | 42 | |
| 7 | 2014 | 35 | |
| 8 | 2017 | 31 | |
| 9 | 2013 | 20 | |
| 10 | 2015 | 20 | |
| 11 | 2017 | 18 | |
| 12 | 2013 | 18 | |
| 13 | 2016 | 17 | |
| 14 | 2015 | 15 | |
| 15 | 2014 | 13 | |
| 16 | 2013 | 13 | |
| 17 | 2015 | 12 | |
| 18 | 2014 | 9 | |
| 19 | 2013 | 8 | |
| 20 | 2015 | 7 |
About C. Rémuzat
C. Rémuzat is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health, Physiology, Immunology and General Health Professions, having authored 62 papers that have together received 760 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (46 papers), Health Systems, Economic Evaluations, Quality of Life (42 papers), Biosimilars and Bioanalytical Methods (9 papers), Pharmaceutical studies and practices (9 papers), Biomedical Ethics and Regulation (9 papers), Economic and Financial Impacts of Cancer (5 papers), Global Health Care Issues (5 papers) and Healthcare Policy and Management (4 papers). The work is most often cited by research in Economics and Econometrics (346 citations), Immunology (166 citations), Pediatrics, Perinatology and Child Health (96 citations), Biological Psychiatry (11 citations) and Pharmacology (35 citations). C. Rémuzat has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Mondher Toumi, Pascal Auquier, Ehab Y. Hanna, A. Millier, Samuel Aballéa, Matthias C. Angermeyer, Bruno Falissard, J Dorey, A. Kornfeld and C. Chouaïd. Their work appears in journals such as Value in Health, International Journal of Social Psychiatry, BMC Psychiatry, Targeted Oncology and Heart Failure Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.